[(2R)-butan-2-yl] 2-[1-(3,4-difluorobenzoyl)-4,6-difluoro-5-hydroxy-2-methylindol-3-yl]acetate
C22H19F4NO4 — CID 158982314
Data last refreshed: (MolForge compound catalog, from PubChem)
About [(2R)-butan-2-yl] 2-[1-(3,4-difluorobenzoyl)-4,6-difluoro-5-hydroxy-2-methylindol-3-yl]acetate
[(2R)-butan-2-yl] 2-[1-(3,4-difluorobenzoyl)-4,6-difluoro-5-hydroxy-2-methylindol-3-yl]acetate (PubChem CID 158982314) has the molecular formula C22H19F4NO4 and a molecular weight of 437.39 g/mol. Its IUPAC name is [(2R)-butan-2-yl] 2-[1-(3,4-difluorobenzoyl)-4,6-difluoro-5-hydroxy-2-methylindol-3-yl]acetate.
Molecular Properties
| Compound Name | [(2R)-butan-2-yl] 2-[1-(3,4-difluorobenzoyl)-4,6-difluoro-5-hydroxy-2-methylindol-3-yl]acetate |
|---|---|
| PubChem CID | 158982314 |
| Molecular Formula | C22H19F4NO4 |
| Molecular Weight | 437.39 g/mol |
| Exact Mass | 437.13 |
| IUPAC Name | [(2R)-butan-2-yl] 2-[1-(3,4-difluorobenzoyl)-4,6-difluoro-5-hydroxy-2-methylindol-3-yl]acetate |
| SMILES | CC[C@@H](C)OC(=O)Cc1c(C)n(C(=O)c2ccc(F)c(F)c2)c2cc(F)c(O)c(F)c12 |
| InChI | InChI=1S/C22H19F4NO4/c1-4-10(2)31-18(28)8-13-11(3)27(17-9-16(25)21(29)20(26)19(13)17)22(30)12-5-6-14(23)15(24)7-12/h5-7,9-10,29H,4,8H2,1-3H3/t10-/m1/s1 |
| InChIKey | JPDQUVRAGQKTGC-SNVBAGLBSA-N |
| XLogP | 4.78 |
| TPSA | 68.53 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 31 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 437.39 |
| LogP ≤ 5 | 4.78 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158982314 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.